A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Clinical trial NCT04786262 · RECRUITING

Trial details

NCT number: NCT04786262
Sponsor: Vertex Pharmaceuticals Incorporated
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Impaired Hypoglycemic Awareness Severe Hypoglycemia

Start date: 2021-03-29
Primary completion: 2027-06-30
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.